CompletedNot Applicable

Comparing Chitosan Sponge With Hydrocolloid as Dressing for Split-thickness Skin Graft Donor Site Wounds

Malaysia22 participantsStarted 2024-05-01

Plain-language summary

The goal of this clinical trial is to compare whether chitosan sponge have same clinical efficacy as a hydrocolloid dressing in treating skin graft donor site wounds. The main questions it aims to answer are: Does chitosan sponge show comparable clinical efficacy as a split-thickness skin graft donor site dressing compared with a conventional hydrocolloid dressing? Participants will: The skin graft donor site wound will be divided into equal halves, and a chitosan sponge and hydrocolloid dressing will be applied to the same patient. The rate of epithelialization will be assessed on days 10, 15, and 20 pain score, pruritus score, ease of removal, exudate level, and bleeding will be assessed on days 10, 15, and 20 The scar outcome will be assessed 2 months and 6 months post-procedure

Who can participate

Age range12 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with partial thickness wounds after split thickness skin graft harvesting * Skin graft donors \> 50cm2 wide * Age \> 12 years old * Consented patients * Patients compliant to the treatment protocol Exclusion Criteria: * Non-compliant patient, causing dressing to dislodge * Patient with history of allergy to seafood * Pregnancy

What they're measuring

Rate of epitheliazation

Timeframe: enrollment till 20 days

Trial details

NCT IDNCT07472465

SponsorHospital Universiti Sains Malaysia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-30

View on ClinicalTrials.gov More Skin Graft Wounds trials